ARO-MMP7 Inhalation Solution
AROMMP7-1001
Phase 2 small_molecule completed
Quick answer
ARO-MMP7 Inhalation Solution for Idiopathic Pulmonary Fibrosis is a Phase 2 program (small_molecule) at ARROWHEAD PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ARROWHEAD PHARMACEUTICALS, INC.
- Indication
- Idiopathic Pulmonary Fibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed